Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Sigyn Therapeutics, Inc. (RGNP) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $1.60 Metrics
OS: 44.2 M
Market cap: $70.8 M
Net debt: $8.29 M
EV: $79.1 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Nov-30-16Dec-31-15
Revenues0.00.00.00.10.00.01.63.3
            Revenue growth  -100.0%405.6%-26.2%  7517.0%
Cost of goods sold0.00.00.00.00.00.00.71.4
Gross profit0.00.00.00.10.00.00.81.8
            Gross margin   75.1%65.7%44.2%53.8%56.1%
Sales and marketing0.0 0.00.00.00.10.30.8
Research and development0.70.70.4     
General and administrative1.51.30.50.60.91.1  
EBITA-2.1-2.0-0.9-0.20.2-1.8-0.4-0.7
            EBITA margin   -151.2%609.3%-4699.6%-28.3%-21.5%
Amortization of intangibles0.00.00.00.10.20.20.10.0
EBIT-2.1-2.0-0.9-0.3-0.1-2.0-0.5-0.7
            EBIT margin   -195.1%-218.6%-5277.4%-32.3%-22.8%
Pre-tax income-2.9-3.0-1.3-3.3-2.3-3.8-0.6-0.8
Income taxes0.00.00.0-0.20.00.00.00.0
            Tax rate0.0%0.0%0.0%7.2%  0.0%0.0%
Earnings from continuing ops-2.9-3.0-1.3-3.3-2.3-3.8-0.6-0.8
Earnings from discontinued ops   0.3-0.3-0.4  
Net income-2.9-3.0-1.3-3.1-2.6-4.3-0.6-0.8
            Net margin   -2145.3%-9243.2%-11061.2%-40.7%-24.4%
 
Diluted EPS($0.08)($0.08)($0.17)($0.04)($0.04)($0.08)($0.06)($0.08)
Shares outstanding (diluted)37.436.47.481.365.147.110.09.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy